BBMP's chicken rice plan for strays sparks cheers, criticism
Prabhu also feeds about 30 dogs in the vicinity, but he waits until nightfall to avoid agitating neighbours who object to feeding strays.
He is happy that the Bruhat Bengaluru Mahanagara Palike (BBMP) has decided to feed chicken and rice to street dogs across all eight zones—around 4,000 in total—at an estimated cost of Rs 2.8 lakh.
"This is a great step to control dog aggression, and a huge relief to people like me who spend from our own pockets. I spend about Rs 2,500 daily on chicken and rice for the dogs, and another Rs 2,000 for 50 kg of bananas that I feed to monkeys and cows," Prabhu told PTI.
According to BBMP's tender document, the civic body plans to feed around 440 dogs in each zone. Each day, at about 11 am, a 400 gm meal of chicken and rice—providing roughly 750 calories—will be served at designated feeding points, it added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
'Denial of preferred food to prisoners not rights violation,' says SC; flags disability gaps in jails
Representative Image NEW DELHI: The Supreme Court on Tuesday said that not providing "preferred or costly food items" to prisoners, including those with disabilities, does not constitute a violation of fundamental rights. Justices J B Pardiwala and R Mahadevan clarified that while Article 21 of the Constitution extends the right to life to all prisoners, it does not grant them the right to demand personalised or luxurious food choices, PTI reported. The bench emphasised, "Mere non-supply of preferred or costly food items cannot ipso facto be treated as a violation of fundamental State's obligation is to ensure that every inmate, including those with disabilities, receives adequate, nutritious, and medically appropriate food, subject to medical certification." The court stated that prisons are correctional facilities rather than extensions of civil society's comforts. Unless resulting in provable harm to health or dignity, the court noted that withholding non-essential or indulgent items does not violate constitutional or human rights. "Prisons are often regarded as the 'tail-end' of the criminal justice system – historically designed for rigid discipline, harsh conditions, and minimal liberties. While modern penological principles advocate rehabilitation over retribution, the current prison infrastructure and operational systems in India remain grossly inadequate – especially when it comes to meeting the needs of prisoners with disabilities," the verdict stated. These observations arose from an appeal by advocate L Muruganantham, who suffers from Becker muscular dystrophy, challenging a Madras High Court order that awarded him Rs 5 lakh compensation. His imprisonment stemmed from a land dispute between his family and another individual. During his incarceration, he alleged inadequate medical care and insufficient protein-rich food, including eggs, chicken and nuts, on a daily basis. The court acknowledged that while the respondent authorities may not be directly responsible for prison facility deficiencies, these issues highlight the urgent need for prison reforms, particularly regarding disability-sensitive infrastructure and protocols. The court recognised the systematic neglect in prison infrastructure, especially concerning disabled prisoners' needs. "Persons with disabilities must be provided healthcare equivalent to that available in the general community. This includes access to physiotherapy, speech therapy, psychiatric care, and assistive devices, such as wheelchairs, hearing aids, or crutches. Prison authorities are under a duty to coordinate with public healthcare systems to ensure uninterrupted care. Logistical or financial limitations cannot be cited to justify a withdrawal of this obligation," it said. The court found most state prison manuals "outdated" and "uninformed" regarding developments in disability law and rights-based discourse. "They frequently conflate sensory or physical disabilities with mental illness or cognitive decline, thereby eroding the distinct legal right to reasonable accommodation. This conflation promotes harmful stereotypes and obstructs disabled inmates from claiming their lawful entitlements," it noted. The court concluded that the state bears both constitutional and moral obligations to protect disabled prisoners' rights, ensuring non-discriminatory treatment and facilitating their rehabilitation and societal reintegration.
News18
3 hours ago
- News18
'I Shop So People Won't Ask Me For Money': Chinese Woman Spends Rs 2.3 Crore On Online Orders
Last Updated: In Jiading, Shanghai, 66-year-old Wang spent over Rs 2 crore on online shopping and had to rent a second apartment just to store the sheer volume of packages In Jiading district of Shanghai, China, a 66-year-old woman has become a viral cautionary tale about online shopping addiction. Wang, who lives alone, has reportedly spent over 2 million yuan (roughly Rs 2.3 crore) on goods she bought online, most of which remain unopened. Her addiction has grown so intense that she had to rent a second apartment just to store the sheer volume of packages she continues to receive. According to Kan Kan News, her home, and now her rented storage flat, are both overflowing with boxes, cosmetics, health supplements, and gold jewelry ordered during live-stream sales. Wang admits she has nowhere left to sleep in her own house. Her underground garage is also packed wall-to-wall with unopened deliveries. The living space, far from livable, has turned into a cluttered maze that's drawn complaints from neighbours. Residents say the piles of boxes have led to foul odours, and infestations of flies and cockroaches. The local residential committee has stepped in multiple times, even coordinating a deep-cleaning drive last year with Wang's consent. But the effort was short-lived. Within months, the packages started piling up again. Wang has spoken candidly about her obsession. She says online shopping gives her mental relief, and even acts as a shield. Years ago, she sold a property in central Shanghai and moved to the suburbs. Ever since, she claims people around her assumed she had excess money and kept asking her for loans. Her solution? Spend the money so there's nothing to lend. 'I buy things to stop people from asking me for money," she told local reporters. Wang's daughter lives overseas, and other family members rarely visit. Authorities reached out to her relatives in an attempt to intervene, but nothing has worked. Mental health experts say what Wang is dealing with isn't just a habit, it's a disorder. Dr Shi Yanfeng from the Shanghai Mental Health Centre says hoarding disorder is often linked to depression and social withdrawal. Treatment takes time, support, and consistent intervention, he explained, adding that long-term care is necessary for people trapped in compulsive hoarding cycles. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Business Standard
4 hours ago
- Business Standard
Zydus Lifesciences gets USFDA Nod for Celecoxib Capsules
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Celecoxib Capsules, marking another addition to its growing U.S. generics portfolio. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones that cause inflammation and pain in the body. It is used to treat pain or inflammation caused by many conditions such as arthritis, ankylosing spondylitis, and menstrual pain. It is also used to treat juvenile rheumatoid arthritis in children who are at least 2 years old. Celecoxib capsules will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad. According to IQVIA MAT data (May 2025), Celecoxib Capsules recorded annual sales of approximately USD 122.6 million in the U.S. market. With this approval, Zydus has now secured a total of 428 final approvals and has filed 492 Abbreviated New Drug Applications (ANDAs) since it began its U.S. regulatory filing process in FY 200304. Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The companys consolidated net profit shed 0.96% to Rs 1,170.9 crore on a 17.21% rise in revenue from operations to Rs 6,290.2 crore in Q4 FY25 over Q4 FY24. The counter shed 0.14% to Rs 967.15 on the BSE.
